give me easy notes on chemotherepy

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive content from Lippincott. Let me compile the full easy notes:

πŸ§ͺ Chemotherapy - Easy Notes

Source: Lippincott Illustrated Reviews: Pharmacology

1. What is Chemotherapy?

Chemotherapy uses chemical drugs to kill or slow the growth of cancer cells. It works mainly by targeting rapidly dividing cells. About 10% of cancer patients achieve cure/prolonged remission with chemo alone; in most cases it produces regression but not a cure. The overall 5-year survival for cancer patients is ~68%.

2. Key Concepts

TermMeaning
Cell cycle specificDrug works only in a specific phase (e.g., S phase)
Cell cycle non-specificDrug works in any phase, including resting cells
MyelosuppressionBone marrow suppression - most common side effect
NadirLowest point of blood cell counts after chemo
Combination therapyMultiple drugs used together to increase efficacy and reduce resistance

3. Classes of Chemotherapy Drugs

A. Alkylating / Adducting Agents

Mechanism: Cross-link DNA strands, preventing replication. Cell cycle non-specific.
DrugKey Notes
CyclophosphamideProdrug; activated by liver CYP450. Unique toxicity = hemorrhagic cystitis (prevented by Mesna + hydration)
IfosfamideSimilar to cyclophosphamide; also causes hemorrhagic cystitis. Neurotoxicity from chloroacetaldehyde metabolite
Cisplatin / CarboplatinPlatinum compounds; cross-link DNA. Cisplatin = nephrotoxic + ototoxic; carboplatin = less toxic
Carmustine / Lomustine (Nitrosoureas)Penetrate the CNS - used for brain tumors. Delayed myelosuppression (4-6 weeks)
BusulfanUsed in CML and bone marrow transplant prep. Causes pulmonary fibrosis
Mnemonic: "Alkylating agents CROSS the DNA bridge"

B. Antimetabolites

Mechanism: Mimic normal building blocks of DNA/RNA; block their synthesis. Cell cycle specific - S phase.
DrugClassKey Notes
Methotrexate (MTX)Folate analogInhibits DHFR. Toxicity rescued by leucovorin. Nephrotoxic at high doses
5-Fluorouracil (5-FU)Pyrimidine analogInhibits thymidylate synthase. Side effect: hand-foot syndrome, mucositis
CapecitabinePyrimidine analogOral prodrug of 5-FU. Also causes hand-foot syndrome
6-Mercaptopurine (6-MP)Purine analogReduce dose by 50-75% with allopurinol (to prevent toxicity)
Cytarabine (Ara-C)Pyrimidine analogUsed in leukemias. High-dose causes cerebellar toxicity
GemcitabinePyrimidine analogUsed in pancreatic, lung, bladder cancer
FludarabinePurine analogUsed in CLL. Causes immunosuppression
Mnemonic: "Antimetabolites are Fake Nucleotides"

C. Antibiotics (Antitumor)

Mechanism: Intercalate DNA, generate free radicals, inhibit topoisomerase II.
DrugKey Notes
Doxorubicin (Adriamycin)Most widely used. Causes cardiomyopathy (dose-dependent); use dexrazoxane for cardiac protection
BleomycinCauses pulmonary fibrosis (unique lung toxicity). Used in testicular cancer, Hodgkin lymphoma
DaunorubicinUsed in AML/ALL; also cardiotoxic

D. Plant Alkaloids

Vinca Alkaloids (from periwinkle plant)

Mechanism: Bind tubulin, prevent spindle formation β†’ cell arrest in M phase.
DrugKey Notes
VincristinePeripheral neuropathy (dose-limiting). Minimal myelosuppression
VinblastineMyelosuppression (dose-limiting). Less neuropathy

Taxanes

Mechanism: Stabilize microtubules (prevent disassembly) β†’ block mitosis.
DrugKey Notes
Paclitaxel (Taxol)Used in breast, ovarian, lung cancer. Causes peripheral neuropathy, hypersensitivity
DocetaxelSimilar to paclitaxel

Topoisomerase Inhibitors

DrugTypeKey Notes
Etoposide (VP-16)Topo II inhibitorUsed in lung cancer, lymphoma
Irinotecan / TopotecanTopo I inhibitors (Camptothecins)Diarrhea is dose-limiting side effect

E. Hormonal Agents

Used mainly in hormone-sensitive cancers (breast, prostate).
DrugMechanismUse
TamoxifenSERM - blocks estrogen receptorsER+ breast cancer
Letrozole / AnastrozoleAromatase inhibitorsPost-menopausal breast cancer
Leuprolide / GoserelinGnRH agonists (cause hormone ablation)Prostate cancer
Flutamide / BicalutamideAndrogen receptor blockersProstate cancer

F. Targeted Therapy

Monoclonal Antibodies (end in -mab)

DrugTargetUse
Trastuzumab (Herceptin)HER2/neuHER2+ breast cancer
RituximabCD20B-cell lymphoma
BevacizumabVEGF (anti-angiogenesis)Colorectal, lung, ovarian cancer
CetuximabEGFRColorectal, head & neck cancer

Kinase Inhibitors (end in -nib)

DrugTargetUse
Imatinib (Gleevec)BCR-ABL tyrosine kinaseCML (Philadelphia chromosome+)
ErlotinibEGFRNon-small cell lung cancer
VemurafenibBRAF V600E mutationMelanoma

G. Immunotherapy (Checkpoint Inhibitors)

Mechanism: Block PD-1, PD-L1, or CTLA-4 to "unleash" the immune system against cancer.
DrugTargetUse
Pembrolizumab (Keytruda)PD-1Melanoma, NSCLC, many others
Nivolumab (Opdivo)PD-1Melanoma, RCC, NSCLC
AtezolizumabPD-L1Bladder, NSCLC
Ipilimumab (Yervoy)CTLA-4Melanoma
Side effects: Immune-related adverse events (irAEs) - colitis, pneumonitis, hepatitis, endocrinopathies

4. Common Side Effects Summary

Side EffectDrugs Responsible
MyelosuppressionAlmost all chemo drugs
Nausea/VomitingCisplatin (most emetogenic), cyclophosphamide
AlopeciaDoxorubicin, cyclophosphamide
CardiomyopathyDoxorubicin, daunorubicin
Pulmonary fibrosisBleomycin, busulfan
Hemorrhagic cystitisCyclophosphamide, ifosfamide β†’ prevented by Mesna
NephrotoxicityCisplatin β†’ give IV fluids + amifostine
Peripheral neuropathyVincristine, paclitaxel, cisplatin
OtotoxicityCisplatin
Hand-foot syndrome5-FU, capecitabine
Neurotoxicity (CNS)High-dose cytarabine (cerebellar), ifosfamide

5. Cell Cycle Targets - Quick Visual

G1 (Growth)  β†’  S phase (DNA synthesis)  β†’  G2  β†’  M phase (Mitosis)
                      ↑                              ↑
              Antimetabolites                  Vinca alkaloids
              (Methotrexate, 5-FU)             Taxanes
                                               Etoposide

Alkylating agents, Antibiotics (Doxorubicin) β†’ Cell Cycle NON-specific

6. Important Drug Interactions to Remember

DrugInteractionEffect
Methotrexate + NSAIDsNSAIDs decrease MTX excretionIncreased MTX toxicity
6-MP + AllopurinolAllopurinol inhibits xanthine oxidase (metabolizes 6-MP)Increase 6-MP levels β†’ reduce dose 50-75%
CyclophosphamideEnhanced toxicity with other immunosuppressants
Leucovorin"Rescue" after high-dose MTXReverses folate depletion

7. Quick Mnemonics

  • "MOPP" - Classic Hodgkin lymphoma regimen: Mechlorethamine, Oncovin (vincristine), Procarbazine, Prednisone
  • "ABVD" - Modern Hodgkin regimen: Adriamycin (doxorubicin), Bleomycin, Vinblastine, Dacarbazine
  • "CMF" - Breast cancer: Cyclophosphamide, Methotrexate, 5-Fluorouracil
  • "Bleomycin = Breathe-o-mycin" β†’ lung toxicity (pulmonary fibrosis)
  • "Cis-PLATin" β†’ think PLATinum β†’ nephrotoxic, give PLENTY of fluids

Source: Lippincott Illustrated Reviews: Pharmacology, Chapter 37 - Anticancer Drugs
This is a shared conversation. Sign in to Orris to start your own chat.